Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

Why Honeywell International (HON) Could Beat Earnings Estimates Again
Why Honeywell International (HON) Could Beat Earnings Estimates Again

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Honeywell

Shopify Trades 37% Below 52-Week High: Is the Stock Still a Buy?
Shopify Trades 37% Below 52-Week High: Is the Stock Still a Buy?

Shopify SHOP shares closed at $114.97 on Monday, which was 36.9% lower than the 52-week high of $182.19 it hit on Oct. 29. SHOP shares have dropped 28.6% year to date, underperforming the broader

Regeneron Boosts Cancer Pipeline Through Telix Collaboration
Regeneron Boosts Cancer Pipeline Through Telix Collaboration

Regeneron Pharmaceuticals REGN announced that it has entered into a strategic collaboration with Telix Pharmaceuticals Limited TLX to co-develop and co-commercialize next-generation

MDLN Gets FDA Warning for Quality Lapses in Angiographic Syringes
MDLN Gets FDA Warning for Quality Lapses in Angiographic Syringes

Medline Inc. (MDLN recently received a warning letter from the FDA, citing multiple violations related to manufacturing and quality system processes at its New York facility. The regulatory action

How Will Visa's Neat Partnership Help Boost Engagement and Growth?
How Will Visa's Neat Partnership Help Boost Engagement and Growth?

Visa Inc. V recently announced a new partnership with Neat to enhance the insurance and medical assistance services embedded within its cards. The collaboration underscores a broader move toward

Johnson & Johnson: A 20% Gain Looks Easy After Q1 Earnings Results
Johnson & Johnson: A 20% Gain Looks Easy After Q1 Earnings Results

Johnson & Johnson’s (NYSE: JNJ) price action entered consolidation in early March. While it may continue moving sideways or even pull back further, those moves are unlikely, given a convergence of

UiPath Stock Slides 39% in Six Months: a Buying Opportunity or a Hold?
UiPath Stock Slides 39% in Six Months: a Buying Opportunity or a Hold?

UiPath Inc. PATH has faced significant selling pressure in recent months, with its stock declining 39% over the past six months and 10% over the last three months. This sharp pullback reflects a

NU Stock Consolidates Over the Past Six Months: Buy, Hold, or Sell?
NU Stock Consolidates Over the Past Six Months: Buy, Hold, or Sell?

Nu Holdings Ltd. NU has delivered impressive operational performance, but its stock has remained largely range-bound over the past six months. While the broader industry has posted solid gains, NU

Adobe's Creative and Marketing Growth Surges: More Upside Ahead?
Adobe's Creative and Marketing Growth Surges: More Upside Ahead?

Adobe ADBE is benefiting from the growth of its Creative and Marketing Professionals segment, driven by AI adoption, core subscription strength and enterprise platform expansion. Creative and

Is Progressive (PGR) a 'Buy' Ahead of Its Upcoming Earnings Announcement?
Is Progressive (PGR) a 'Buy' Ahead of Its Upcoming Earnings Announcement?

Leading insurance provider Progressive PGR is set to report Q1 results on Wednesday before the opening bell. A Zacks Rank #3 (Hold), Progressive missed the earnings mark in two of the past four

Can lululemon Restore Pricing Power Against Increasing Discounts?
Can lululemon Restore Pricing Power Against Increasing Discounts?

lululemon athletica inc. LULU has been taking steps to restore its pricing power; however, this will take time with disciplined execution. The pricing power weakened in 2025, reflected by higher

2 Stocks Poised to Deliver Big Growth This Earnings Season
2 Stocks Poised to Deliver Big Growth This Earnings Season

The 2026 Q1 earnings season is in full swing, with a wide variety of companies on the reporting docket in the coming weeks. It looks to be another period of positivity, though geopolitical concerns